... shares. Cell Therapeutics went public in 1996 at $10 per share, which equates to a reverse split-adjusted, first-day trading price of $12,000 per share. Today, a Cell Therapeutics' stock trades for $1.08. James Bianco, Cell Therapeutics' Chairman ...
http://www.thestreet.com/story/11899120/1/cell-therapeutics-addicted-to-reverse-stock-splits.html?cm_ven=RSSFeed&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+tsc%2Ffeeds%2Frss%2Flatest-stories+%28TheStreet.com+Latest+Headlines%29
http://www.thestreet.com/story/11899120/1/cell-therapeutics-addicted-to-reverse-stock-splits.html?cm_ven=RSSFeed&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+tsc%2Ffeeds%2Frss%2Flatest-stories+%28TheStreet.com+Latest+Headlines%29
No comments:
Post a Comment